Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts

Prostate

Volumn 52, Issue 3, 2002, Pages 201-212

  Rice, Lori ^a   Samedi, Von G ^a   Medrano, Theresa A ^a   Sweeney, Carol A ^a   Baker, Henry V ^a   Stenstrom, Anne ^a   Furman, Jaime ^a   Shiverick, Kathleen T ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Isoflavones; Mice; Microarrays; Prostate cancer; Xenografts

Indexed keywords

BIOCHANIN A; COMPLEMENTARY DNA; DIMETHYL SULFOXIDE; DNA FRAGMENT; THYMIDINE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; DNA SYNTHESIS; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; TUMOR XENOGRAFT; UNINDEXED SEQUENCE;

ANIMALS; ANTICARCINOGENIC AGENTS; CELL CYCLE PROTEINS; CELL DIVISION; DNA, COMPLEMENTARY; GENISTEIN; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0036680526     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10100     Document Type: Article

References (63)

1. Western diet and western diseases: Some hormonal and biochemical mechanisms and associations
2. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption
3. Changes in prostate cancer incidence and treatment in USA
4. Molecular genetics and epidemiology of prostate carcinoma
5. Racial differences in adenocarcinoma of the prostate in North American men
6. Phyto-estrogens and western diseases
7. Cancer epidemiology in populations of the United States with emphasis on Hawaii and California and Japan
8. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones
9. Are the differences between estradiol and other estrogens, naturally occurring or synthetic, merely semantical?
10. Prostate Cancer prevention: Review of target populations, pathological biomarkers, and chemopreventive agents
11. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tryosine autophosphorylation
12. Effect of genistein on in vitro and in vivo models of cancer
13. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer
14. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture
15. Antiproliferative effects of isoflavones on human cancer lines established from the gastrointestinal tract
16. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines
17. Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistant gene
18. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by p21 induction, G2/M arrest, and apoptosis
19. Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids
20. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements
21. Infection of human T lymphoid cells by human herpesvirus 6 blocked by two unrelated protein tyrosine kinase inhibitors, biochanin A and herbimycin
22. Tyrosine kinase inhibition: An approach to drug development
23. Protein tyrosine kinase inhibition: Mechanism-based discovery of antitumor agents
24. Use of a mammalian cell culture benzo[a]pyrene metabolism assay for the detection of potential anticarcinogens from natural products: Inhibition of metabolism by biochanin A, an isoflavone from trifolium pratense L
25. Effects of biochanin A on metabolism, DNA binding and mutagenicity of benzo[a]pyrene in mammalian cell cultures
26. Inhibitory effects of biochanin A on mouse lung tumor induced by benzo[a]pyrene
27. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A
28. Effects of protein tyrosine kinase inhibitors with different modes of action on topoisomerase activity and death of IL-2-dependent CTLL-2 cells
29. Clinical applications of anticancer drugs targeted to topoisomerase II
30. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer
31. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice
32. WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells
33. WAF1/CIP1, reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells
34. Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP
35. Growth inhibition of prostate cell lines in vitro by phyto-estrogens
36. Genistein-induced apoptosis of prostate cancer cells is associated by a specific decrease in focal adhesion kinase activity
37. Differential effects of genistein, biochanin A, and coumestrol on cell cycle, proliferation and apoptosis in human prostate cancer LNCaP cells
38. Increased UDP-glucuronosyltransferase activity and decreased prostatic specific antigen production by biochanin A in prostate cancer cells
39. LNCaP model of human prostatic carcinoma
40. An in vitro assay procedure to test chemotherapeutic drugs on cells from human solid tumors
41. "Western blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A
42. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
43. Expression profiling using cDNA microarrays
44. Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice
45. The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A
46. Biology of disease. Prostate cancer. Therapeutic, diagnostic, and basic studies
47. Phytoestrogens and prostate cancer: Possible preventive role
48. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones
49. Phytoestrogens. Epidemiology and a possible role in cancer protection
50. Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice
51. DNA microarrays in drug discovery and development
52. Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays
53. The genetics of cancer - A 3D model
54. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates
55. The folate receptor as a potential therapeutic anticancer target
56. Identification of a family of closely related human ubiquitin conjugating enzymes
57. The tyrosine negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
58. Comprehensive genome sequence analysis of a breast cancer amplicon
59. Inhibition of prostate specific antigen expression by genistein in prostate cancer cells
60. Modulation of endogenous beta-tubulin isotype expression as a result of human betaIII cDNA transfection into prostate carcinoma cells
61. Cloning and sequencing of human betaIII-tubulin cDNA: Induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents
62. Identification of a brain- and reproductive-organs-specific gene responsive to DNA damage and retinoic acid
63. Differential expression of a stress-modulating gene, BRE, in the adrenal gland, in adrenal neoplasia, and in abnormal adrenal tissues